Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy - Wikidata - wikimedia - TriplyDB

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

http://www.wikidata.org/entity/Q35090262

about

Aptamers: A promising chemical antibody for cancer therapy Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems Tracking Transplanted Stem Cells Using Magnetic Resonance Imaging and the Nanoparticle Labeling Method in Urology Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing Current progress of aptamer-based molecular imaging Aptamer-Mediated Targeted Delivery of Therapeutics: An Update Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches DNA-Based Nanobiosensors as an Emerging Platform for Detection of Disease.Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics.Radiation-induced tumor neoantigens: imaging and therapeutic implications.Magnetofection: a reproducible method for gene delivery to melanoma cells.Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Aptamers Selected by Cell-SELEX for Molecular Imaging.Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor Aptamer-targeted cell-specific RNA interference Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy.MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.GCPII imaging and cancer.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Enabling individualized therapy through nanotechnology Aptamers from cell-based selection for bioanalytical applications EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates.Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release.Cell-specific aptamer-mediated targeted drug delivery Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Gold-Coated Fe3O4 Nanoroses with Five Unique Functions for Cancer Cell Targeting, Imaging and Therapy.Aptamers: active targeting ligands for cancer diagnosis and therapy Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.Tumor-targeted drug delivery with aptamers Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells Aptamer technology for tracking cells' status & function.Generating aptamers by cell-SELEX for applications in molecular medicine Molecular imaging in tracking tumor stem-like cells Current progress of RNA aptamer-based therapeutics.Utilizing the folate receptor for active targeting of cancer nanotherapeutics Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applications Kinetic assembly of near-IR-active gold nanoclusters using weakly adsorbing polymers to control the size

P2860

Q26766832-B2F36E95-B8D1-4D3A-89A8-998226D6243D Q26782485-0A725DA0-1C09-4F98-97A0-32A4157D5C2E Q26785642-C3E8B072-D697-491B-8DFB-45F1E9C79750 Q26825644-091A38ED-54AD-425C-82A4-6CCE637B340C Q27000472-178AC147-A2D8-4B6C-9B33-EA7AFAAB6851 Q28066827-2DD154CC-838E-4D2C-9E23-BF0853CAA10A Q28391849-79DBEA22-2475-4334-9042-8B819072F1C2 Q30354223-C8697A6D-5802-412B-89AE-AFABBB947E72 Q30406478-F20CCBE7-8E39-4A28-9782-1C1E8EDEDEAB Q30462393-66290461-B998-41FC-822A-E2F5C2D91078 Q30473856-77171113-3C5C-457B-AB76-9335BFF095F8 Q30559364-F547AD42-8B5B-4249-92FE-2EBCA3D7031F Q30827270-5393188E-519E-4391-BD7B-80A0FDAF0409 Q31026416-939302B9-BB19-456C-8716-3B92F6E11581 Q33647681-F8C29248-620F-4CD8-99D0-0F6A8B1563E5 Q33717239-810CD7C6-5FDC-47FF-96CE-C5502B5A8248 Q33740377-14EBCF55-6CC2-456C-BCAE-47551870E542 Q33779847-70D61349-5A8E-4420-A37A-55451A641152 Q33827632-3D593797-9D9E-4D17-A372-DA21C5494619 Q33834772-6C2AF7E8-094B-43A7-AF06-87CEDE0A678A Q33917755-EB5209C1-2851-4D44-93F3-B00263335FCC Q33920514-A89EC06A-3D3E-48AB-9CBB-5C11613A3560 Q34075391-0BF47076-DB6C-4229-A028-ED1E0FE85E64 Q34076231-58E87773-D66B-4A39-8B0C-CD69120919D9 Q34384411-7FDC6048-3187-46DC-8CCC-E42A04801FDA Q34599718-9147D919-F7E9-461F-AE8F-F7C43107B243 Q34652685-33C9BD43-1067-4EB3-84CC-6DE88205439B Q34698624-5D0EC0AF-F156-413B-9629-C641BA1E2080 Q34703015-8EE11E0F-49CB-47B1-A987-C0F0C01FEB3E Q35086493-18079734-E8CD-4062-83A5-95DD58B90DE1 Q35102454-B118C325-7777-40A8-990D-FA0D314014E7 Q35490874-1037B9C9-B46A-423E-97AE-4296C0F6AE0B Q35622986-116028D8-8B52-4E32-B91E-5D05AB2703CF Q35673895-FC02C802-FE09-42BB-B968-19D18B55F80C Q35866033-27A3FA2E-3E76-42CD-B8F2-4807A4E65E66 Q35909465-D95454C2-2F48-49B6-ADBC-CB25E412AE46 Q36365202-1BA47DDD-2036-41A2-827D-F442E14021E8 Q36463444-F92DCDE8-BA52-421D-AD5E-85ABD837CDC8 Q37137356-3768B381-E0FA-4FD1-9B10-6812B268610A Q37281417-DBD012A5-78AA-4989-B0A0-EB8E15ACFABA

P2860

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

http://www.wikidata.org/entity/Q35090262

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@ast

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@en

type

label

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@ast

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@en

prefLabel

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@ast

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@en

P1433

Q35090262-97FB47EA-2EF4-41BE-A137-47783130F075

P1476

Q35090262-31EDEB65-D954-4503-A188-31FCB0075211

P2093

Q35090262-0DC3063B-95F3-4388-B4EC-E4CADBF4EADA

Q35090262-5B0586DC-F941-42FE-B38F-BC5F85B639E7

Q35090262-78272086-0902-40DC-9EC3-2DE403DB1449

Q35090262-887429FE-D56C-439A-A4E2-A2EA9A83B0A4

Q35090262-AE3B8D6C-82F3-4D9D-B27A-B1D9F815B210

Q35090262-B891EE5D-AE0B-484E-B951-B251A749D3BB

Q35090262-BB04D24B-7F0F-40E0-A139-FA262B44A687

Q35090262-C97B2B6F-E5EF-45E8-BBD8-EF6C75D2307E

Q35090262-FBCD3A5D-E99B-40A9-B516-17BF73896330

P2860

Q35090262-0A35DF23-8231-4B19-9199-D67CB21C9BF8

Q35090262-12849FB8-6643-44E3-A7AE-F21F8FD6C3DD

Q35090262-14FC7C3A-B89F-4D93-81AD-CD714AC0B166

Q35090262-23AB7685-E3E2-46E3-919A-B9B0A03720AD

Q35090262-28665DF6-0DC5-4B66-A010-34DCB679CCF4

Q35090262-3E32DCD4-0970-4382-BE39-BEE4A7B8118E

Q35090262-3E95B87A-8D89-4ED3-8FC1-067C26F25AF4

Q35090262-46EE460C-572C-4A8F-AE3D-735FBB3FAC8E

Q35090262-5E97DFF6-C4B6-4E5A-A742-60B4547F8CD2

Q35090262-684592D8-A2C0-405D-96C4-9AE35A6234AE

P304

Q35090262-6CFEE3F1-0520-430F-A9DE-325756BFAE1A

P31

Q35090262-6D4D0BEF-716C-4D39-A7D2-01EF372B47F8

P356

Q35090262-60F2D0A3-2BC2-42E9-BAEC-286679F712DA

P433

Q35090262-EAAB9E8B-3D85-4F0A-A291-6259ADEC8EED

P478

Q35090262-53866DD7-EEE9-482B-8C45-A7C2F047B299

P50

Q35090262-585F94EC-A81A-47A8-929C-288DD0AD2E87

Q35090262-6A5E11CA-33CC-48F6-AF4C-A3DA233DE6C8

Q35090262-94305494-C904-46AF-9CFC-080B2876844F

Q35090262-CCD757AC-4015-4130-BD14-CA200EFC7D36

Q35090262-ED5BC572-BF2F-4FAA-B90A-793C529FB796

P577

Q35090262-77B6985B-6F74-4C74-9346-0CA718EEA6C0

P5875

Q35090262-CB9C48EE-2AB3-4020-81CE-F184525914BF

P698

Q35090262-647E5076-ACB9-4682-9B9D-FC869A75AEED

P921

Q35090262-210CCD6A-FAF3-4B90-B395-D73C37C54925

P932

Q35090262-7C87330E-15DF-4272-B13E-C8D646100FD5

P356

P1433

P1476

Superparamagnetic iron oxide n ...... ate cancer imaging and therapy

@en

P2093

Christophoros C Vasilliou

http://www.w3.org/2001/XMLSchema#string

Frank Alexis

http://www.w3.org/2001/XMLSchema#string

Liangfang Zhang

http://www.w3.org/2001/XMLSchema#string

Mariam Shaikh

http://www.w3.org/2001/XMLSchema#string

Michael J Cima

http://www.w3.org/2001/XMLSchema#string

Neil H Bander

http://www.w3.org/2001/XMLSchema#string

Robert Langer

http://www.w3.org/2001/XMLSchema#string

Sangyong Jon

http://www.w3.org/2001/XMLSchema#string

Vaishali Bagalkot

http://www.w3.org/2001/XMLSchema#string

P2860

ErbB receptors: from oncogenes to targeted cancer therapies

Sensitive, noninvasive detection of lymph node metastases

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Trastuzumab--mechanism of action and use in clinical practice

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Targeted delivery of multifunctional magnetic nanoparticles.

The prostate: MR imaging and spectroscopy. Present and future.

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

P304

1311-1315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.200800091

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Omid C. Farokhzad

Philip W. Kantoff

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5237983

http://www.w3.org/2001/XMLSchema#string

P698

18613203

http://www.w3.org/2001/XMLSchema#string

P921

P932

3131111

http://www.w3.org/2001/XMLSchema#string